AMGEN (AMGN) P/S (1999 - 2026)
AMGEN (AMGN) P/S from Nov 1, 1999 to Jul 21, 2026. The TTM AMGEN (AMGN) P/S is 5.31. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/S
Annual P/S change of AMGEN (AMGN)
| Year | P/S | Change |
|---|---|---|
| 2026 | 5.31 | +10.67% |
| 2025 | 4.80 | +14.62% |
| 2024 | 4.19 | -27.11% |
| 2023 | 5.74 | +7.93% |
| 2022 | 5.32 | +10.07% |
| 2021 | 4.83 | -7.55% |
| 2020 | 5.23 | -14.30% |
| 2019 | 6.10 | +18.24% |
| 2018 | 5.16 | -6.00% |
| 2017 | 5.49 | +13.76% |
| 2016 | 4.83 | -14.58% |
| 2015 | 5.65 | -6.41% |
| 2014 | 6.04 | +30.98% |
| 2013 | 4.61 | +22.07% |
| 2012 | 3.78 | +3.36% |
| 2011 | 3.65 | +7.47% |
| 2010 | 3.40 | -11.58% |
| 2009 | 3.84 | +176.25% |
| 2008 | 1.39 | -0.15% |
| 2007 | 1.39 | +40.70% |
| 2006 | 0.99 | -13.38% |
| 2005 | 1.14 | +22.93% |
| 2004 | 0.93 | +3.82% |
| 2003 | 0.90 | +27.82% |
| 2002 | 0.70 | -14.35% |
| 2001 | 0.82 | -11.73% |
| 2000 | 0.93 | +6.46% |
| 1999 | 0.87 | N/A |
Comparison AMGEN (AMGN) P/S with competitors
AMGEN (AMGN) P/S is 5.31.
| Ticker | Name | P/S | Upside |
|---|---|---|---|
| OGN | Organon & Company | 0.57 | -89.17% |
| NVO | Novo Nordisk | 0.66 | -87.53% |
| GRFS | Grifols SA | 0.67 | -87.36% |
| AMRN | Amarin Corp | 1.39 | -73.83% |
| SCLX | Scilex Holding Company | 1.92 | -63.94% |
| SNY | Sanofi | 2.18 | -58.89% |
| PFE | Pfizer Inc | 2.18 | -58.89% |
| BMY | Bristol-Myers Squibb Company | 2.40 | -54.83% |
| BIIB | Biogen Inc | 2.93 | -44.83% |
| GSK | GSK Plc | 3.22 | -39.29% |
| MRK | Merck & Co Inc | 4.54 | -14.59% |
| AZN | Astrazeneca plc | 4.58 | -13.66% |
| NVS | Novartis AG | 5.07 | -4.53% |
| GILD | Gilead Sciences Inc | 5.43 | +2.25% |
| JNJ | Johnson & Johnson | 6.34 | +19.38% |
| ABBV | Abbvie Inc | 7.15 | +34.64% |
| LLY | Lilly(Eli) & Company | 14.28 | +168.90% |